Evidence map›Paper›PMID 36121125›Full record

ArticleThe EMBO journal2022

SOX9 maintains human foetal lung tip progenitor state by enhancing WNT and RTK signalling.

Dawei Sun, Oriol Llora Batlle, Jelle van den Ameele, John C Thomas, Peng He, Kyungtae Lim, Walfred Tang, Chufan Xu, Kerstin B Meyer, Sarah A Teichmann and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. New developments and applications of human organoids.Nature reviews. Molecular cell biology · 2026
    Review
  3. bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Cellular plasticity and regenerative mechanisms in the lung.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. SOX on tumors, a comfort or a constraint?Cell death discovery · 2024
    Review
  17. Article
  18. Review
  19. The lung mesenchyme in development, regeneration, and fibrosis.The Journal of clinical investigation · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Dawei SunWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0003-1551-4349
Oriol Llora BatlleWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-8424-9705
Jelle van den AmeeleWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2744-0810
John C ThomasWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0003-2425-8412
Peng HeWellcome Sanger Institute, Cambridge, UK.ORCID 0000-0002-2457-3554
Kyungtae LimWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-6044-2191
Walfred TangWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-5803-1681
Chufan XuWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.
Kerstin B MeyerWellcome Sanger Institute, Cambridge, UK.ORCID 0000-0001-5906-1498
Sarah A TeichmannWellcome Sanger Institute, Cambridge, UK.
John C MarioniWellcome Sanger Institute, Cambridge, UK.
Stephen P JacksonWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-9317-7937
Andrea H BrandWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2089-6954
Emma L RawlinsWellcome Trust/CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7426-3792
University of Cambridge · GBEuropean Bioinformatics Institute · GBWellcome Sanger Institute · GB

Funding

Medical Research Council MR/P009581/1Medical Research Council MR/R006237/1Medical Research Council MR/S035907/1Wellcome Trust 103792Wellcome Trust 105839Wellcome Trust 206388/Z/17/ZWellcome Trust 225221
6 · The paper itself

Abstract

The balance between self-renewal and differentiation in human foetal lung epithelial progenitors controls the size and function of the adult organ. Moreover, progenitor cell gene regulation networks are employed by both regenerating and malignant lung cells, where modulators of their effects could potentially be of therapeutic value. Details of the molecular networks controlling human lung progenitor self-renewal remain unknown. We performed the first CRISPRi screen in primary human lung organoids to identify transcription factors controlling progenitor self-renewal. We show that SOX9 promotes proliferation of lung progenitors and inhibits precocious airway differentiation. Moreover, by identifying direct transcriptional targets using Targeted DamID, we place SOX9 at the centre of a transcriptional network, which amplifies WNT and RTK signalling to stabilise the progenitor cell state. In addition, the proof-of-principle CRISPRi screen and Targeted DamID tools establish a new workflow for using primary human organoids to elucidate detailed functional mechanisms underlying normal development and disease.

Indexed as

LungSOX9 Transcription FactorStem CellsCell DifferentiationHumansSignal TransductionSOX9 protein, humanSOX9 Transcription FactorCRISPRi screenETVsLung organoidsSOX9Targeted DamID

Identifiers

PMID36121125
PMCPMC9627674
OpenAlexW4296322355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.